01/04/2022
4:00pm
Advances in Immunoengineering: Fundamentals and Cutting Edge Advances (2022)
The immunoengineering field is transforming cancer, autoimmunity, regeneration, and transplantation treatments by combining the diverse and complex fields of engineering and immunology. There is a significant need to train engineers in immunology and immunologists in quantitative engineering techniques. Moreover, there is a need to bridge basic immunological discoveries with advances in clinical application. This virtual workshop will review immune system fundamentals and components, engineering strategies to modulate the immune system, and clinical applications.
After attending this workshop, the learner will demonstrate the ability to:
– Review the fundamentals and recent discoveries in the function of the immune system.
– Identify engineering strategies to manipulate the immune system.
– Describe the clinical applications of immunoengineering.
Target Audience
The workshop is designed for graduate students, medical students, residents, and fellows in engineering, immunology, and related fields. Engineering and clinical faculty, and industry members will benefit from the course as well.
Dates and Time
Every Tuesday and Thursday, January 4 – 27, 2022, from 4:00 pm – 5:30 pm ET.
Registration
You only need to register once to attend all dates. Registration is allowed at any time.
Credit
This workshop is eligible for CME credit and offered as a two-credit course for Johns Hopkins students. The course is listed as EN.580.543 (for undergraduate students) and EN.580.843 (for graduate students) Independent Study: Advances in Immunoengineering in SIS. Students need to register for the course and the workshop.
Agenda
Week 1 – T-Cell Engineering and Immunometabolism
Tuesday, January 4, 2022 | Thursday, January 6, 2022 |
Cassian Yee
T Cell Therapy of Cancer: the New Math |
Pedro Romero
Modulating Antigen-specific CD8 T Cell Differentiation for Immunotherapy of Cancer |
Kellie N. Smith
Integrated Multi-Omics for Tumor-Reactive T Cell Profiling |
Erika Pearce
Mitochondrial Shape-Shifting in the CD4+ T Cell Response |
Week 2 – Regenerative Immunology and T Cell Programming
Tuesday, January 11, 2022 | Thursday, January 13, 2022 |
Stephen Badylak
Immunoengineering … Finally! |
Greg Delgoffe
Metabolic Reprogramming to Improve T Cell Function |
Jennifer Elisseeff
Immune Changes with Aging and Implications for Regenerative Medicine |
Jonathan Schneck
Engineering Artificial Antigen Presenting Cells, aAPC, for Cancer Immunotherapy: From Bench to Bedside |
Week 3 – Immunotherapy, Vaccine, and Autoimmunity
Tuesday, January 18, 2022 | Thursday, January 20, 2022 |
Matthias Stephan
Creating Living Drugs with Synthetic Compounds |
Robert Seder
Systemic Delivery of a Nanoparticle Neoantigen Cancer Vaccine Generates Effective Antitumor Immunity Through CD8+ T Cells and Innate Stimulation |
Ankur Singh
Decoding Immunity Using Engineered Immune Organoids |
Pere Santamaria
In Vivo Re-programming of Autoantigen-experienced T-follicular Helper Cells for the Treatment of Autoimmunity |
Week 4 – Immunoengineering, Tissue Context, and Immunotherapies
Tuesday, January 25, 2022 | Thursday, January 27, 2022 |
David Mooney
Biomaterials for T Cell Immunity |
Donna Farber
Localized Adaptation and Tissue Residence of Immune Cells |
Megan Sykes
Tracking the Human Alloresponse in Transplant Recipients |
John Wherry
Immunity to SARS-CoV-2 Vaccination |